{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T07:33:02Z","timestamp":1786260782580,"version":"build-2736575974"},"reference-count":84,"publisher":"Elsevier BV","issue":"37-39","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.vaccine.2006.05.071","type":"journal-article","created":{"date-parts":[[2006,6,11]],"date-time":"2006-06-11T12:00:42Z","timestamp":1150027242000},"page":"6288-6299","source":"Crossref","is-referenced-by-count":14,"title":["Assessing the introduction of universal varicella vaccination in the Netherlands"],"prefix":"10.1016","volume":"24","author":[{"given":"Hein J.","family":"Boot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester E.","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly A.","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Ardine","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjeerd G.","family":"Kimman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2006.05.071_bib1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/426514","article-title":"Varicella-vaccine failure in an outbreak in an elementary school in Minnesota","volume":"191","author":"Arya","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2006.05.071_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1542\/peds.72.3.291","article-title":"Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays","volume":"72","author":"Asano","year":"1983","journal-title":"Pediatrics"},{"issue":"11\/12","key":"10.1016\/j.vaccine.2006.05.071_bib3","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0264-410X(02)00431-0","article-title":"The cost-effectiveness of routine childhood varicella vaccination in Germany","volume":"21","author":"Banz","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2006.05.071_bib4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00431-005-1637-8","article-title":"Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents","volume":"164","author":"Bonhoeffer","year":"2005","journal-title":"Eur J Pediatr"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2006.05.071_bib5","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/jmv.10313","article-title":"Epidemiology of varicella-zoster virus in England and Wales","volume":"70","author":"Brisson","year":"2003","journal-title":"J Med Virol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2006.05.071_bib6","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1002\/jmv.10317","article-title":"Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV","volume":"70","author":"Brisson","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2006.05.071_bib7","series-title":"Valuing the benefit of varicella vaccination: comparison of willingness to pay and quality-adjusted life-years","author":"Brisson","year":"2004"},{"issue":"22","key":"10.1016\/j.vaccine.2006.05.071_bib8","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJM196905292802201","article-title":"Prevention of varicella by zoster immune globulin","volume":"280","author":"Brunell","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.05.071_bib9","unstructured":"CBG. PROVARIVAX. Medicine Register of the Netherlands [Dutch] 2004; RVG 29215."},{"key":"10.1016\/j.vaccine.2006.05.071_bib10","unstructured":"CBS statline. Overlevingstabel naar leeftijd op laatste verjaardag 1995\/1996\u20131999\/2000 [http:\/\/www.statline.cbs.nl]. CBS statline."},{"key":"10.1016\/j.vaccine.2006.05.071_bib11","unstructured":"CDC. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMRW 1996;45(RR-11):1\u201336."},{"key":"10.1016\/j.vaccine.2006.05.071_bib12","unstructured":"CDC. National, state, and urban area vaccination coverage levels among children aged 19\u201335 months\u2014United States, 2000. MMWR Morb Mortal Wkly Rep 2001;50(30):637\u2013641."},{"key":"10.1016\/j.vaccine.2006.05.071_bib13","unstructured":"CDC. Outbreak of varicella among vaccinated children\u2014Michigan, 2003. MMWR Morb Mortal Wkly Rep 2004;53(18):389\u2013392."},{"key":"10.1016\/j.vaccine.2006.05.071_bib14","doi-asserted-by":"crossref","unstructured":"Coudeville L, Brunot A, Szucs TD, Dervaux B. The economic value of childhood varicella vaccination in France and Germany. Value Health 2005;8(3):209\u2013222.","DOI":"10.1111\/j.1524-4733.2005.04005.x"},{"issue":"7","key":"10.1016\/j.vaccine.2006.05.071_bib15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/jama.294.7.845","article-title":"Varicella vaccine, cost-effectiveness analyses, and vaccination policy","volume":"294","author":"Davis","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2006.05.071_bib16","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1542\/peds.2004-0012","article-title":"Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States","volume":"114","author":"Davis","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2006.05.071_bib17","unstructured":"de Melker H, Berbers G, Hahne S, van den Hof S, de Wit A, Boot, HJ. The epidemiology of varicella and zoster in the Netherlands: implications for VZV vaccination strategy. Submitted to vaccine: JVAC-D-05-00528, 2005."},{"key":"10.1016\/j.vaccine.2006.05.071_bib18","unstructured":"de Melker HE, Hahne SJM, de Boer IM. The national immunisation programme in the Netherlands: current status and potential future developments. Bilthoven, The Netherlands: RIVM, 2005. Report no.: 210021002\/2005."},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.071_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/340868","article-title":"An outbreak of varicella among children attending preschool and elementary school in Illinois","volume":"35","author":"Dworkin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2006.05.071_bib20","unstructured":"Food and Drugs Administration (USA). Product approval information\u2014licensing action of measles, mumps, rubella and varicella virus vaccine live. ProQuad (Merck & Co. Inc.). [Internet 2005 September; http:\/\/www.fda.gov\/cber\/products\/mmrvmer090605.htm]."},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.071_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/341089","article-title":"Younger age at vaccination may increase risk of varicella vaccine failure","volume":"186","author":"Galil","year":"2002","journal-title":"J Infect Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2006.05.071_bib22","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa021662","article-title":"Outbreak of varicella at a day-care center despite vaccination","volume":"347","author":"Galil","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2006.05.071_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/biol.1997.0089","article-title":"Live attenuated varicella vaccine for prevention of herpes zoster","volume":"25","author":"Gershon","year":"1997","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2006.05.071_bib24","first-page":"93","article-title":"Varicella-zoster virus: prospects for control","volume":"10","author":"Gershon","year":"1995","journal-title":"Adv Pediatr Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.071_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0891-5520(05)70268-3","article-title":"Live-attenuated varicella vaccine","volume":"15","author":"Gershon","year":"2001","journal-title":"Infect Dis Clin North Am"},{"issue":"24","key":"10.1016\/j.vaccine.2006.05.071_bib26","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMe020138","article-title":"Varicella vaccine\u2014are two-doses better than one?","volume":"347","author":"Gershon","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.05.071_bib27","series-title":"Vaccines","first-page":"475","article-title":"Varicella vaccine","author":"Gershon","year":"1999"},{"key":"10.1016\/j.vaccine.2006.05.071_bib28","series-title":"Clinical virology","first-page":"413","article-title":"Varicella-zoster virus","author":"Gershon","year":"2002"},{"issue":"25","key":"10.1016\/j.vaccine.2006.05.071_bib29","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1016\/j.vaccine.2003.10.042","article-title":"Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes zoster epidemiology","volume":"23","author":"Goldman","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.05.071_bib30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00000441-196209000-00013","article-title":"Chickenpox: an epidemiological review","volume":"244","author":"Gordon","year":"1962","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2006.05.071_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcv.2005.02.003","article-title":"Varicella vaccination of children in the United States: assessment after the first decade 1995\u20132005","volume":"33","author":"Grose","year":"2005","journal-title":"J Clin Virol"},{"issue":"13","key":"10.1016\/j.vaccine.2006.05.071_bib32","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1128\/JVI.78.13.6799-6807.2004","article-title":"Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype","volume":"78","author":"Grose","year":"2004","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.05.071_bib33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0891-5520(05)70318-4","article-title":"Epidemiologic effects of varicella vaccination","volume":"10","author":"Halloran","year":"1996","journal-title":"Infect Dis Clin N Am"},{"issue":"2","key":"10.1016\/j.vaccine.2006.05.071_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00019053-200422020-00005","article-title":"Economic evaluation of varicella vaccination programmes: a review of the literature","volume":"22","author":"Hammerschmidt","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2006.05.071_bib35","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson RE","year":"1965","journal-title":"Proc R Soc Med"},{"issue":"25\/26","key":"10.1016\/j.vaccine.2006.05.071_bib36","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1016\/j.vaccine.2004.03.064","article-title":"Scientific commentary","volume":"22","author":"Jumaan","year":"2004","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2006.05.071_bib37","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","article-title":"Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella","volume":"191","author":"Jumaan","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.05.071_bib38","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.vaccine.2006.03.022","article-title":"Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs","volume":"24","author":"Kimman","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2006.05.071_bib39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-3476(95)70106-0","article-title":"Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine","volume":"127","author":"Krause","year":"1995","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2006.05.071_bib40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2006.05.071_bib41","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0264-410X(91)90189-D","article-title":"Oka\/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies","volume":"9","author":"Kuter","year":"1991","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2006.05.071_bib42","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/infdis\/152.5.869","article-title":"Determination of immunity to varicella-zoster virus by means of an intradermal skin test","volume":"152","author":"LaRussa","year":"1985","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2006.05.071_bib43","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1542\/peds.105.5.e60","article-title":"Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group","volume":"105","author":"Laupland","year":"2000","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2006.05.071_bib44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM198002213020807","article-title":"Airborne transmission of chickenpox in a hospital","volume":"302","author":"Leclair","year":"1980","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2006.05.071_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/422041","article-title":"An elementary school outbreak of varicella attributed to vaccine failure: policy implications","volume":"190","author":"Lee","year":"2004","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2006.05.071_bib46","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1086\/378502","article-title":"Development of resistance to acyclovir during chronic infection with the Oka-vaccine strain of varicella-zoster virus, in an immunosuppressed child","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2006.05.071_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jama.271.5.375","article-title":"Cost-effectiveness of a routine varicella vaccination program for US children","volume":"271","author":"Lieu","year":"1994","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.vaccine.2006.05.071_bib48","doi-asserted-by":"crossref","first-page":"8349","DOI":"10.1128\/JVI.78.15.8349-8358.2004","article-title":"Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping","volume":"78","author":"Loparev","year":"2004","journal-title":"J Virol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2006.05.071_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0163-4453(98)80156-4","article-title":"Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection","volume":"36","author":"Nathwani","year":"1998","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2006.05.071_bib50","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"issue":"3\/4","key":"10.1016\/j.vaccine.2006.05.071_bib51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(02)00459-0","article-title":"Reactogenicity and immunogenicity of a live attenuated tetravalent measles\u2013mumps\u2013rubella\u2013varicella (MMRV) vaccine","volume":"21","author":"Nolan","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.05.071_bib52","article-title":"Handleiding voor kostenonderzoek: methoden en standaard kostprijzen voor economische evaluatie in de gezondheidszorg","author":"Oostenbrink","year":"2004","journal-title":"College Voor Zorgverzekeringen"},{"issue":"22","key":"10.1016\/j.vaccine.2006.05.071_bib53","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.071_bib54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr"},{"issue":"5 Pt 2","key":"10.1016\/j.vaccine.2006.05.071_bib55","first-page":"49S","article-title":"Cost-consequence models for varicella-zoster virus infections","volume":"15","author":"Paul","year":"1995","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.071_bib56","article-title":"Varicella zoster virus vaccination policies and surveillance strategies in Europe","volume":"10","author":"Pinot de moire","year":"2005","journal-title":"Eurosurveillance"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.071_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10198-003-0201-6","article-title":"Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations","volume":"5","author":"Postma","year":"2004","journal-title":"Eur J Health Econ"},{"issue":"11","key":"10.1016\/j.vaccine.2006.05.071_bib58","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0021-9681(78)90072-3","article-title":"The utility of different health states as perceived by the general public","volume":"31","author":"Sackett","year":"1978","journal-title":"J Chronic Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2006.05.071_bib59","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1086\/324503","article-title":"Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome","volume":"33","author":"Saint-Leger","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"8 Pt 1","key":"10.1016\/j.vaccine.2006.05.071_bib60","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/sj.jp.7200457","article-title":"The congenital varicella syndrome","volume":"20","author":"Sauerbrei","year":"2000","journal-title":"J Perinatol"},{"key":"10.1016\/j.vaccine.2006.05.071_bib61","series-title":"Varicella-zoster virus","first-page":"187","article-title":"Epidemiology and clinical manifestations","author":"Seward","year":"2000"},{"issue":"6","key":"10.1016\/j.vaccine.2006.05.071_bib62","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00006454-200106000-00014","article-title":"Update on varicella","volume":"20","author":"Seward","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"17","key":"10.1016\/j.vaccine.2006.05.071_bib63","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.287.17.2211","article-title":"Varicella vaccine and shingles","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2006.05.071_bib64","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2006.05.071_bib65","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2006.05.071_bib66","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/01.inf.0000172901.29621.e9","article-title":"Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2006.05.071_bib67","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9343(00)00445-9","article-title":"Cost-effectiveness of vaccination strategies in adults without a history of chickenpox","volume":"108","author":"Smith","year":"2000","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2006.05.071_bib68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1386-6532(03)00112-4","article-title":"New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka\u2013varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis","volume":"29","author":"Takayama","year":"2004","journal-title":"J Clin Virol"},{"issue":"27\/28","key":"10.1016\/j.vaccine.2006.05.071_bib69","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.vaccine.2004.03.043","article-title":"An economic evaluation of varicella vaccination in Italian adolescents","volume":"22","author":"Thiry","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.071_bib70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00019053-200321010-00002","article-title":"Economic evaluations of varicella vaccination programmes: a review of the literature","volume":"21","author":"Thiry","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"9334","key":"10.1016\/j.vaccine.2006.05.071_bib71","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet"},{"issue":"3 Pt 1","key":"10.1016\/j.vaccine.2006.05.071_bib72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1542\/peds.113.3.455","article-title":"Chickenpox outbreak in a highly vaccinated school population","volume":"113","author":"Tugwell","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.071_bib73","first-page":"18","article-title":"Twijfels over kindervaccinatie","volume":"60","author":"Van de Bovenkamp-Meijer","year":"2005","journal-title":"Medische Contact"},{"issue":"7","key":"10.1016\/j.vaccine.2006.05.071_bib74","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"Vazquez","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2006.05.071_bib75","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMp048320","article-title":"Varicella vaccine and infection with varicella-zoster virus","volume":"352","author":"Vazquez","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2006.05.071_bib76","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1469-0691.2004.01020.x","article-title":"Effects of varicella vaccination on herpes zoster incidence","volume":"10","author":"Wagenpfeil","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2006.05.071_bib77","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/clinids\/20.2.316","article-title":"Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine","volume":"20","author":"Watson","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2006.05.071_bib78","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM198405313102201","article-title":"Live attenuated varicella virus vaccine. Efficacy trial in healthy children","volume":"310","author":"Weibel","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.05.071_bib79","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1542\/peds.89.2.354","article-title":"Letter to editor","volume":"89","author":"White","year":"1992","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2006.05.071_bib80","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/clinids\/24.5.925","article-title":"Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group","volume":"24","author":"White","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2006.05.071_bib81","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2006.05.071_bib82","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.284.10.1271","article-title":"Postlicensure safety surveillance for varicella vaccine","volume":"284","author":"Wise","year":"2000","journal-title":"JAMA"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2006.05.071_bib83","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0264-410X(01)00276-6","article-title":"Seroprevalence of varicella-zoster virus in the German population","volume":"20","author":"Wutzler","year":"2001","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2006.05.071_bib84","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jama.294.7.797","article-title":"Impact of varicella vaccination on health care utilization","volume":"294","author":"Zhou","year":"2005","journal-title":"JAMA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06006748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06006748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T18:02:38Z","timestamp":1683482558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06006748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":84,"journal-issue":{"issue":"37-39","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0264410X06006748"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.05.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}